AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King? The Motley Fool 23:46 Mon, 22 Jun
AbbVie’s Long-Term Vision For I&I Comes Into Focus With Apogee Assets Scrip Pharma Intelligence 23:25 Mon, 22 Jun
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer The Motley Fool 23:16 Mon, 22 Jun
Market movers: Alphabet, Definium Therapeutics, Micron, Getty Images, Apogee Therapeutics… Proactive Investors (US) 19:39 Mon, 22 Jun
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monday Benzinga 17:16 Mon, 22 Jun Article paywall
AbbVie deepens immunology legacy in $10.9bn Apogee buyout Pharmaceutical Technology 16:46 Mon, 22 Jun
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders PR Newswire (Press Release) 16:39 Mon, 22 Jun
AbbVie to buy Waltham’s Apogee Therapeutics in nearly $11 billion deal Boston Globe 15:28 Mon, 22 Jun Article paywall
AbbVie To Acquire Immunology Drug Maker Apogee For $10.9 Bln Cash; Shares Climb RTT News 15:04 Mon, 22 Jun
Apogee Therapeutics Shares Surge 46 Percent to 132.70 on Positive Clinical Developments International Business Times - AU Edition 15:01 Mon, 22 Jun
Apge Stock Alert: Halper Sadeh LLC is Investigating Whether Apogee Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders Business Wire (Press Release) 14:28 Mon, 22 Jun
AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition Benzinga 14:23 Mon, 22 Jun Article paywall
AbbVie to buy biotech firm Apogee Therapeutics for $10.9bn ShareCast 14:10 Mon, 22 Jun Article paywall
AbbVie bets US$10.9 billion on Apogee in next-generation immunology growth push BNN Bloomberg 12:57 Mon, 22 Jun
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio AbbVie (Press Release) 12:00 Mon, 22 Jun
Why Apogee Therapeutics (APGE) Is Up 8.0% After Phase 2 Win And $1.3 Billion Blackstone Deal Simply Wall St 22:19 Wed, 10 Jun
Apogee Therapeutics (APGE) Valuation Check After Positive Phase 2 APEX Data And US$1.3b Blackstone Financing Simply Wall St 18:20 Tue, 09 Jun
Apogee Enterprises Announces Date for Fiscal 2027 First Quarter Results Business Wire (Press Release) 11:36 Fri, 05 Jun
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart WebWire 14:14 Fri, 29 May
Apogee Therapeutics lines up $1.3B strategic financing for zumilokibart program Proactive Investors (US) 19:53 Thu, 28 May
Wedbush Reaffirms Apogee Therapeutics At Outperform; Lifts Price Target To $135 RTT News 09:49 Thu, 28 May
Apogee Doubles Its Cash Position As It Reports New Phase II Zumilokibart Data Scrip Pharma Intelligence 23:20 Wed, 27 May
Apogee secures up to $1.3 billion from Blackstone to advance eczema drug Rock Hill Herald 14:07 Wed, 27 May Article paywall
Apogee Therapeutics Stock Tumbles 11% Despite Positive Phase 2 Results For Zumilokibart In AD RTT News 12:18 Wed, 27 May
